Concurrent MPL515 and JAK2V617F mutations in myelofibrosis:: chronology of clonal emergence and changes in mutant allele burden over time

被引:78
|
作者
Lasho, Terra L.
Pardanani, Animesh
McClure, Rebecca F.
Mesa, Ruben A.
Levine, Ross L.
Gilliland, D. Gary
Tefferi, Ayalew
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Dana Farber Canc Inst, Rochester, MN USA
[3] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
myelofibrosis; MPLW515L; MPLW515K; essential thrombocythaemia;
D O I
10.1111/j.1365-2141.2006.06348.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MPLW515L/K and JAK2V617F can co-exist in myelofibrosis with myeloid metaplasia (MMM). The chronology of clonal emergence was studied in three such cases using serially stored bone marrow. At diagnosis, a major MPL515 mutant clone was accompanied by a minor JAK2V617F clone in all three instances. At 25 time points over a period of 4-8 years, allele burden fluctuated but remained high for MPLW515L/K and low for JAK2V617F. We conclude that MPLW515L/K and JAK2V617F are both early events in MMM and allele burden, rather than the mere presence of these mutations, might be relevant to phenotypic variation in myeloproliferative disorders.
引用
收藏
页码:683 / 687
页数:5
相关论文
共 50 条
  • [42] JAK2 V617F, MPL W515L and JAK2 exon 12 mutations in Chinese patients with primary myelofibrosis
    Xia, Jun
    Lu, Mi-ze
    Jiang, Yuan-qiang
    Yang, Guo-hua
    Zhuang, Yun
    Sun, Hong-li
    Shen, Yun-feng
    CHINESE JOURNAL OF CANCER RESEARCH, 2012, 24 (01) : 72 - 76
  • [43] JAK2V617F, CALR and MPL515L/K mutations and plateletcrit in essential thrombocythemia: A single centre's experience
    Ceylan, Cengiz
    Ozyilmaz, Berk
    Kirbiyik, Ozgur
    Ugur, Mehmet Can
    Ozer, Ozge
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (04)
  • [44] DOES ALLELE BURDEN IMPORT IN MYELOFIBROSIS WITH JAK2 V617F MUTATION?
    Maria Isabel, Montero Cuadrado
    Francisco Jose, Marquez Malaver
    Cruz Estrella, Carrillo
    Canale Silvia, Garcia
    Lucia, Mezquita
    Javier, Delgado
    Caro Rocio, Marin
    Francisco Jose, Martin Dominguez
    Nancy, Rodriguez
    Campos Jose, Gonzalez
    Jose Francisco, Falantes
    Jose Antonio, Perez Simon
    HAEMATOLOGICA, 2021, 106 (10) : 258 - 258
  • [45] RUXOLITINIB REDUCES JAK2P.V617F ALLELE BURDEN IN PATIENTS WITH MYELOFIBROSIS
    Deininger, M.
    Radich, J.
    Burn, T.
    Huber, R.
    Paranagama, D.
    Verstovsek, S.
    HAEMATOLOGICA, 2015, 100 : 265 - 265
  • [46] Bone marrow JAK2V617F allele burden and clinical correlates in polycythemia vera
    A Tefferi
    J J Strand
    T L Lasho
    R A Knudson
    C M Finke
    N Gangat
    A Pardanani
    C A Hanson
    R P Ketterling
    Leukemia, 2007, 21 : 2074 - 2075
  • [47] IN JAK2V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS, BLEEDING RISK CORRELATES WITH ALLELE BURDEN
    Bertozzi, I.
    Cosi, E.
    Santarossa, C.
    Bogoni, G.
    Fabris, F.
    Randi, M. L.
    HAEMATOLOGICA, 2017, 102 : 811 - 811
  • [48] JAK2V617F, CALR and MPL mutations and bone marrow histology in patients with essential thrombocythemia
    Pich, Achille
    Riem, Ludovica
    di Celle, Paola Francia
    Beggiato, Eloise
    Benevolo, Gmlia
    Godio, Laura
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 : S46 - S46
  • [49] Clinical relevance of JAK2 (V617F) mutant allele burden
    Passamonti, Francesco
    Rumi, Elisa
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (01): : 7 - 10
  • [50] Detection of CALR gene mutations in JAK2V617F and MPL unmutated chronic myeloproliferative neoplasms
    Strnad, Milica
    Todoric-Zivanovic, Biljana
    Atanaskovic, Lavinika
    Elez, Marija
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 1041 - 1041